Skip to content
The GLP-1 Verdict
Menu

Head-to-head verdict

Telos Rx vs CoreAge Rx

Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, no pay-to-win placement.

Grade B · #21

Telos Rx

Carries one of the deepest published catalogs on the board — compounded semaglutide and tirzepatide plus needle-free oral and microdosed routes, PT-141, intranasal NAD+ and a wall of recovery peptides — and backs it with a checkable LegitScript certification and HIPAA compliance, but the verdict docks it hard because every line is compounded, not FDA-approved, and the pricing turns opaque the moment you look past the headline GLP-1 tiers.

Visit Telos Rx
vs
WinnerGrade A · #1

CoreAge Rx

The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.

Visit CoreAge Rx

The verdict

Winner: CoreAge Rx

CoreAge Rx takes it with a higher Verdict Score — 94/100 to 85/100 (grade A vs B). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Telos Rx still earns its place — patients who want a single LegitScript-verified operator carrying far more than a GLP-1 — oral and microdosed options, peptides and bioidentical HRT — and will accept compounded-only meds and a long annual lock-in in exchange for the lowest published prices.

Factor by factor

Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.

83Real-world results92
82Price honesty97
87Prescriber access96
92Formulary choice88
83Cancellation fairness95
84Member support93

Price, coverage & features

MetricTelos RxCoreAge Rx
Verdict Score85/10094/100
GradeBA
Semaglutide$49/mo (microdosed, annual)$149/mo
Tirzepatide$99/mo (annual)$349/mo
CoverageNot publicly listedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesNo

Telos Rx

What we like

  • Unusually deep published menu — compounded semaglutide and tirzepatide alongside PT-141, intranasal NAD+, and recovery peptides (sermorelin, ipamorelin, CJC-1295, BPC-157)
  • Needle-free and oral routes, including oral and microdosed tirzepatide, for the needle-averse
  • LegitScript-certified and HIPAA-compliant, with US-based providers and pharmacies, plus HSA/FSA and free 48-hour shipping
  • Low published GLP-1 entry — from $49/mo microdosed and $99/mo tirzepatide on annual plans

The caveats

  • Everything is compounded, not FDA-approved — including the peptides, several of which are research-grade with limited human evidence
  • Pricing turns opaque outside the headline GLP-1 tiers, and the cheapest rates require a long annual lock-in (short plans run $145/$199/$399 in the first month)
  • No named clinicians or leadership, and only a thin body of public reviews
  • States served are not published, so confirm your state is covered before you sign up

CoreAge Rx

What we like

  • Flat, all-in monthly price with no intro-rate step-ups after month one
  • Both compounded semaglutide and tirzepatide on one account
  • Available in all 50 states
  • Straightforward, low-friction cancellation

The caveats

  • Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
  • No FDA-approved brand-name option (compounded only)
  • Does not yet publicly name its 503A/B pharmacy partner

Also worth a look

Patients who want a single LegitScript-verified operator carrying far more than a GLP-1 — oral and microdosed options, peptides and bioidentical HRT — and will accept compounded-only meds and a long annual lock-in in exchange for the lowest published prices.

Visit Telos Rx Read the full Telos Rx review →

Our pick — visit

Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.

Visit CoreAge Rx Read the full CoreAge Rx review →

Keep comparing

Or browse the full comparison hub and the complete rankings.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.